Jun 26, 2023 09:45AM
Jun 24, 2023 06:49AM
May 30, 2023 04:35PM
May 10, 2023 04:10AM
May 10, 2023 01:06AM
Feb 7, 2023 08:28PM
Feb 2, 2023 07:00AM CTI BioPharma to Participate in Upcoming Investor Conferences in February 2023
Jan 24, 2023 07:18PM
Jan 5, 2023 07:00AM
Dec 20, 2022 06:35PM
Dec 11, 2022 06:30PM
Nov 30, 2022 07:00AM
Nov 8, 2022 04:05PM
Nov 7, 2022 04:05PM CTI BioPharma Reports Third Quarter 2022 Financial Results
Nov 3, 2022 09:00AM
Oct 27, 2022 04:05PM
Oct 17, 2022 04:05PM
Sep 21, 2022 09:09PM
Sep 21, 2022 06:00PM
Aug 22, 2022 04:05PM
Aug 8, 2022 04:05PM CTI BioPharma Reports Second Quarter 2022 Financial Results
Aug 1, 2022 08:37AM
Jun 14, 2022 04:05PM
Jun 10, 2022 07:01AM
Jun 10, 2022 07:00AM
Jun 3, 2022 08:00AM
Jun 2, 2022 04:05PM
May 27, 2022 04:05PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 26, 2022 05:00PM
May 12, 2022 04:05PM
May 10, 2022 07:00AM
May 5, 2022 04:05PM
Apr 28, 2022 04:05PM
Apr 14, 2022 07:01AM
Apr 14, 2022 07:00AM NCCN Guidelines® Recommend VONJO™ (pacritinib) for the Treatment of Myeloproliferative Neoplasms
Apr 6, 2022 04:05PM
Mar 31, 2022 04:01PM
Mar 2, 2022 04:05PM
Mar 1, 2022 06:01AM
Feb 28, 2022 07:18PM
Feb 18, 2022 04:05PM
Jan 6, 2022 04:30PM CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dec 13, 2021 09:00AM
Dec 2, 2021 04:30PM
Nov 30, 2021 05:30PM
Nov 30, 2021 05:30PM
Nov 29, 2021 07:00AM
Nov 9, 2021 04:05PM
Nov 4, 2021 09:04AM CTI BioPharma Announces Presentations at the 63rd American Society of Hematology Meeting
Oct 14, 2021 04:05PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All